BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Waldum HL, Gustafsson B, Fossmark R, Qvigstad G. Antiulcer drugs and gastric cancer. Dig Dis Sci. 2005;50 Suppl 1:S39-S44. [PMID: 16184420 DOI: 10.1007/s10620-005-2805-4] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 1.4] [Reference Citation Analysis]
Number Citing Articles
1 Srikanta B, Siddaraju M, Dharmesh S. A novel phenol-bound pectic polysaccharide from Decalepis hamiltonii with multi-step ulcer preventive activity. World J Gastroenterol 2007; 13(39): 5196-5207 [PMID: 17876890 DOI: 10.3748/wjg.v13.i39.5196] [Cited by in CrossRef: 35] [Cited by in F6Publishing: 32] [Article Influence: 2.5] [Reference Citation Analysis]
2 Fossmark R, Qvigstad G, Waldum HL. Gastric cancer: Animal studies on the risk of hypoacidity and hypergastrinemia. World J Gastroenterol 2008; 14(11): 1646-1651 [PMID: 18350594 DOI: 10.3748/wjg.14.1646] [Cited by in CrossRef: 23] [Cited by in F6Publishing: 17] [Article Influence: 1.8] [Reference Citation Analysis]
3 Liu W, Baker SS, Trinidad J, Burlingame AL, Baker RD, Forte JG, Virtuoso LP, Egilmez NK, Zhu L. Inhibition of lysosomal enzyme activities by proton pump inhibitors. J Gastroenterol 2013;48:1343-52. [DOI: 10.1007/s00535-013-0774-5] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 3.8] [Reference Citation Analysis]
4 Waldum HL, Qvigstad G. Proton pump inhibitors and gastric neoplasia. Gut 2007;56:1019-20; author reply 1020. [PMID: 17566032 DOI: 10.1136/gut.2006.116434] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
5 Teixeira MZ. Rebound acid hypersecretion after withdrawal of gastric acid suppressing drugs: new evidence of similitude. Homeopathy. 2011;100:148-156. [PMID: 21784332 DOI: 10.1016/j.homp.2011.05.003] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
6 Megala J, Geetha A. Free radical-scavenging and H+, K+-ATPase inhibition activities of Pithecellobium dulce. Food Chemistry 2010;121:1120-8. [DOI: 10.1016/j.foodchem.2010.01.059] [Cited by in Crossref: 15] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
7 Zaitseva O, Khudyakov A, Sergushkina M, Solomina O, Polezhaeva T. Pectins as a universal medicine. Fitoterapia 2020;146:104676. [DOI: 10.1016/j.fitote.2020.104676] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 18.0] [Reference Citation Analysis]
8 Nanjundaiah SM, Annaiah HN, Dharmesh SM. Gastroprotective Effect of Ginger Rhizome (Zingiber officinale) Extract: Role of Gallic Acid and Cinnamic Acid in H(+), K(+)-ATPase/H. pylori Inhibition and Anti-Oxidative Mechanism. Evid Based Complement Alternat Med 2011;2011:249487. [PMID: 19570992 DOI: 10.1093/ecam/nep060] [Cited by in Crossref: 37] [Cited by in F6Publishing: 35] [Article Influence: 3.7] [Reference Citation Analysis]
9 Maity P, Biswas K, Chattopadhyay I, Banerjee RK, Bandyopadhyay U. The use of neem for controlling gastric hyperacidity and ulcer. Phytother Res 2009;23:747-55. [PMID: 19140119 DOI: 10.1002/ptr.2721] [Cited by in Crossref: 24] [Cited by in F6Publishing: 18] [Article Influence: 2.0] [Reference Citation Analysis]
10 Scarpignato C, Pelosini I, Di Mario F. Acid suppression therapy: Where do we go from here? Dig Dis. 2006;24:11-46. [PMID: 16699262 DOI: 10.1159/000091298] [Cited by in Crossref: 61] [Cited by in F6Publishing: 55] [Article Influence: 4.1] [Reference Citation Analysis]
11 Megala J, Geetha A. Antiulcerogenic activity of hydroalcoholic fruit extract of Pithecellobium dulce in different experimental ulcer models in rats. Journal of Ethnopharmacology 2012;142:415-21. [DOI: 10.1016/j.jep.2012.05.011] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 1.8] [Reference Citation Analysis]
12 Adinortey MB, Ansah C, Adinortey CA, McGiboney J, Nyarko A. In vitro H+/K+-ATPase Inhibition, Antiradical Effects of a Flavonoid-rich Fraction of Dissotis rotundifolia, and In silico PASS Prediction of its Isolated Compounds. J Nat Sci Biol Med 2018;9:47-53. [PMID: 29456393 DOI: 10.4103/jnsbm.JNSBM_104_17] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
13 Hauso O, Gustafsson BI, Kidd M, Waldum HL, Drozdov I, Chan AK, Modlin IM. Neuroendocrine tumor epidemiology: contrasting Norway and North America. Cancer. 2008;113:2655-2664. [PMID: 18853416 DOI: 10.1002/cncr.23883] [Cited by in Crossref: 314] [Cited by in F6Publishing: 298] [Article Influence: 24.2] [Reference Citation Analysis]
14 Nandy N, Hanson JA, Strickland RG, Mccarthy DM. Solitary Gastric Carcinoid Tumor Associated with Long-Term Use of Omeprazole: A Case Report and Review of the Literature. Dig Dis Sci 2016;61:708-12. [DOI: 10.1007/s10620-015-4014-0] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 4.3] [Reference Citation Analysis]
15 Sheen E, Triadafilopoulos G. Adverse effects of long-term proton pump inhibitor therapy. Dig Dis Sci. 2011;56:931-950. [PMID: 21365243 DOI: 10.1007/s10620-010-1560-3] [Cited by in Crossref: 187] [Cited by in F6Publishing: 167] [Article Influence: 18.7] [Reference Citation Analysis]
16 Bamford M. 3 H+/K+ ATPase Inhibitors in the Treatment of Acid-Related Disorders. Progress in Medicinal Chemistry Volume 47. Elsevier; 2009. pp. 75-162. [DOI: 10.1016/s0079-6468(08)00203-8] [Cited by in Crossref: 13] [Cited by in F6Publishing: 3] [Article Influence: 1.1] [Reference Citation Analysis]
17 Júnior FE, de Oliveira DR, Boligon AA, Athayde ML, Kamdem JP, Macedo GE, da Silva GF, de Menezes IR, Costa JG, Coutinho HDM, Kerntopf MR, Posser T. Protective effects of Croton campestris A. St-Hill in different ulcer models in rodents: Evidence for the involvement of nitric oxide and prostaglandins. Journal of Ethnopharmacology 2014;153:469-77. [DOI: 10.1016/j.jep.2014.03.005] [Cited by in Crossref: 28] [Cited by in F6Publishing: 21] [Article Influence: 4.0] [Reference Citation Analysis]
18 Poulsen AH, Christensen S, McLaughlin JK, Thomsen RW, Sørensen HT, Olsen JH, Friis S. Proton pump inhibitors and risk of gastric cancer: a population-based cohort study. Br J Cancer. 2009;100:1503-1507. [PMID: 19352380 DOI: 10.1038/sj.bjc.6605024] [Cited by in Crossref: 82] [Cited by in F6Publishing: 74] [Article Influence: 6.8] [Reference Citation Analysis]
19 McCarthy DM. Adverse effects of proton pump inhibitor drugs: clues and conclusions. Curr Opin Gastroenterol 2010;26:624-31. [PMID: 20802330 DOI: 10.1097/MOG.0b013e32833ea9d9] [Cited by in Crossref: 90] [Cited by in F6Publishing: 19] [Article Influence: 9.0] [Reference Citation Analysis]